Gerald L. Feldman, M.D., PhD
Gerald L. Feldman, M.D., PhD
Office AddressMolecular Genetics Laboratory, Hutzel Building/WG71. 4701
Administrative ContactMichelle Phillips
Position TitleProfessor of Pathology Molecular Medicine and Genetics and Pediatrics
Dr. Feldman is Board-certified by the American Board of Medical Genetics in Clinical Genetics and Clinical and Biochemical Genetics. He has been involved in Molecular Diagnostics for over 20 years, directing laboratories that provide state of the art molecular testing for inherited disorders and hematopathology and solid tumors.
Dr. Feldman provides expertise in the clinical, molecular and biochemical diagnosis of genetic disorders. He also provides expertise in the management and treatment of patients with inborn errors of metabolism. He serves as the course director for Advanced Medical Genetics and is involved in the education and training of medical genetics residents and fellows and pathology residents and fellows.
Bachelor of Arts, Indiana University, 1975
MS, Medical Genetics, Indiana University, 1977
Ph.D. in Human Genetics (1981)
Virginia Commonwealth University,Medical College of Virginia, Richmond, VA, USA
Virginia Commonwealth University, Medical College of Virginia School of Medicine, Richmond, VA, USA
Medical Education Responsibilities
Co-course Director of Advanced Medical Genetics (MBG 7800)
Co-course director, Year 1 Medical Genetics
Director of the Medical Genetics Residency Program and Medical Biochemical Genetics Fellowship Program
Areas of InterestMolecular Genetics and Molecular Medicine
Residency in Pediatrics
1984-1987: Baylor College of Medicine, Houston, TX, USA
Fellowship in Clinical Genetics and Clinical Biochemical/Molecular Genetics
1987-1990: Baylor College of Medicine and Institute for Molecular Genetics, Houston, TX, USA
1. Korf BR, Feldman GL and Wiesner G, 2005, Report of the Banbury summit meeting on training of physicians in medical genetics, Genet Med, 7: 433-438.
2. Kalman L, Johnson MA, Beck J, Berry-Kravis E, Buller A, Casey B, Feldman GL, et. Al, 2007, Development of genomic reference materials for Huntington disease genetic testing, Genet Med, 9: 719–23.
3. Monaghan, KG, Feldman, GL, Palomaki, GE and Spector EB, 2008, Ashkenazi Jewish reproductive screening working group and the molecular subcommittee of the ACMG laboratory quality assurance committee; Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population, Genet Med, 10: 57-72.
4. Nahhas, F, Garbern J, Feely, Feldman, GL, 2009, An Intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling, Am J Med Genet, 149A: 732-6.
5. Feldman GL and Monaghan KG, 2010, Prenatal diagnosis of cystic fibrosis, In: Genetic disorders and the fetus: diagnosis, prevention and treatment. Johns Hopkins University Press, 6th edition. Milunsky A, editor.
6. Zhang H, Salimnia H, Bentley G, Liu W, Phillips M, Feldman GL and Palutke P, 2011. Two morphologically and immunophenotypically distinct cell populations within a composite lymphoma arise from a common precursor. J Hematopathol 4:164-174.
7. Busse T, Graham Jr JM, Feldman GL, Perin J, Catherwood A, Knowlton R, Rappaport EF, Emanuel B, Driscoll DA and Saitta SC, 2011. High resolution genomic arrays identify CNVs that phenocyopy the chromosome 22q11.2 deletion syndrome. Hum Mut 32:91-97.
8. Lachbawan FL, Weck KE, Kant JA, Feldman GL and Schriver I, 2012. Verification of performance specifications of a molecular test: Cystic Fibrosis carrier testing using the Luminex Bead Array. Arch. Pathol Lab Med 136:14-19.
9. Nahhas F, Monroe T, Prior TW, Botma PI, Fang J, Snyder PJ, Talbott SI and Feldman GL, 2012. Evaluation of the Human FMR1 PCR Reagents (RUO) to amplify the FMR1 gene: Testing in a Clinical Diagnostic Laboratory. Genet Test Mol Biomarkers, 16:187-192.